Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-29

Clinical Trial Update: Lybrido for Female Sexual Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial of Lybrido for hypoactive sexual desire disorder in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lybrido

Snippet

Sponsor: Emotional Brain NY Inc. | Conditions: Hypoactive Sexual Desire Disorder | Phase 2 | Status: COMPLETED